Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit?

Bruno Eduardo Pereira Laporte Estela Gelain Junges Laporte Paula Fonseca Aarestrup Matheus Fonseca Aarestrup Fernando Monteiro Aarestrup

Published in: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia (2022)

Patients with breast or gynecological cancers who are receiving treatment or are in the 5-year posttreatment period should be included in the priority group for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination.

Keyphrases

respiratory syndrome coronavirus
sars cov
coronavirus disease
young adults
smoking cessation